← Back to patent-cliff list
CAS 67291-61-6
5-ethyl-2-methoxyaniline
Codes: Zeprumetostat-016
Application context (from source-drug indications)
Peripheral T-cell lymphomaZeprumetostatLymphomaZeprumetostatT-cell lymphomaZeprumetostatMyelodysplastic syndromeZeprumetostatAcute lymphoblastic leukaemiaZeprumetostatAcute myeloid leukaemiaZeprumetostat
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Zeprumetostat | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-ethylphenol→1-ethyl-4-methoxybenzene→1-(5-ethyl-2-methoxyphenyl)ethan-1-one→5-ethyl-2-methoxyaniline→4-ethyl-7-methoxyindoline-2,3-dione→methyl 2-amino-6-ethyl-3-methoxybenzoate→methyl 2-amino-5-bromo-6-ethyl-3-methoxybenzoate→methyl 3-bromo-2-ethyl-6-iodo-5-methoxybenzoate→methyl 3-bromo-2-ethyl-5-hydroxy-6-iodobenzoate→1-(prop-2-yn-1-yl)piperidine→methyl 6-bromo-5-ethyl-2-(piperidin-1-ylmethyl)benzofuran-4-carboxylate→6-bromo-5-ethyl-2-(piperidin-1-ylmethyl)benzofuran-4-carboxylic acid hydrogen chloride
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.